PFE · Pfizer Inc · Webcasts, Transcripts & Audio
$28.89
+0.06 (+0.21%)
At close · Nov 13
Return incl. dividend (before tax)
Play latest call
Q3 2026 earnings call transcript
Market Cap
$164.67B
Shares
5.70B
Volume · Nov 13
21.6M
Avg daily vol (3M)
33.41M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Pfizer Inc Webcasts
Earnings calls, investor updates, investor days and conferences for Pfizer Inc (PFE), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.
Pull transcripts and briefs through the earnings call transcript API or MCP →
Add these events to your calendar (.ics)
Conference
Investor event
2026-11-17
Pfizer Inc (PFE) November 17, 2026 Conference
Scheduled
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q3
2026-11-03
Pfizer Inc (PFE) Q3 2026 Earnings Call Transcript
Confident tone
LOE transition and capital allocation
Vaccines and China obesity launch
Cost savings and financial discipline
Revenue
$16.58B
▼ 0.4% YoY Diluted EPS
$0.56
▼ 9.7% YoY Gross margin
75.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Conference
Investor event
2026-09-22
Pfizer Inc (PFE) September 22, 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Conference
Investor event
2026-09-14
Pfizer Inc (PFE) September 14, 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q2
2026-08-04
Pfizer Inc (PFE) Q2 2026 Earnings Call Transcript
Confident tone
COVID-19 franchise variability
Oncology portfolio (PADCEV, mephrometastat, 4404)
Obesity/GLP-1 (berobenadide)
Revenue
$15.03B
▲ 2.6% YoY Diluted EPS
$-0.04
▼ 107.8% YoY Gross margin
72.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Conference
Investor event
2026-06-08
Pfizer Inc (PFE) June 8, 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Conference
Investor event
2026-06-03
Pfizer Inc (PFE) June 3, 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q1
2026-05-05
Pfizer Inc (PFE) Q1 2026 Earnings Call Transcript
Confident tone
Capital Allocation & Dividend
Obesity / Metsera Acquisition
Oncology Pipeline & Seagen
Revenue
$14.45B
▲ 5.4% YoY Diluted EPS
$0.47
▼ 9.6% YoY Gross margin
75.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Annual General Meeting
Investor event
2026-04-23
Pfizer Inc (PFE) April 23, 2026 Annual General Meeting Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY25 · Q4
2026-02-03
Pfizer Inc (PFE) Q4 2025 Earnings Call Transcript
Confident tone
AI scaling across the enterprise
R&D catalysts and pipeline milestones
Obesity / Metsera pipeline
Revenue
$17.56B*
▼ 1.2% YoY Gross margin
70.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Conference
Investor event
2026-01-12
Pfizer Inc (PFE) January 12, 2026 Conference
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY25 · Q3
2025-12-16
Pfizer Inc (PFE) Q3 2025 Earnings Call Transcript
Confident tone
Late-stage pipeline catalysts and upcoming data
Metsera acquisition and competitive dispute
R&D pipeline and oncology assets
Revenue
$16.65B
▼ 5.9% YoY Diluted EPS
$0.62
▼ 20.5% YoY Gross margin
74.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2025-08-05
Pfizer Inc (PFE) Q2 2025 Earnings Call Transcript
Confident tone
Capital allocation and business development
Vaccine portfolio
Full-year 2025 guidance raise
Revenue
$14.65B
▲ 10.3% YoY Diluted EPS
$0.51
▲ 5000% YoY Gross margin
74.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2025-04-29
Pfizer Inc (PFE) Q1 2025 Earnings Call Transcript
Positive tone
Capital allocation and dividend
Q1 financial results and 2025 guidance
Loss of exclusivity (LOE) planning
Revenue
$13.71B
▼ 7.8% YoY Diluted EPS
$0.52
▼ 5.5% YoY Gross margin
79.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q4
2025-02-04
Pfizer Inc (PFE) Q4 2024 Earnings Call Transcript
Positive tone
R&D pipeline progress
Business development strategy
Oncology franchise strength
Revenue
$17.76B*
▲ 21.9% YoY Gross margin
66.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q3
2024-12-18
Pfizer Inc (PFE) Q3 2024 Earnings Call Transcript
Confident tone
Pipeline advancement
Obesity / oral GLP-1
Seagen integration
Revenue
$17.70B
▲ 31.2% YoY Diluted EPS
$0.78
Gross margin
70.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q2
2024-07-30
Pfizer Inc (PFE) Q2 2024 Earnings Call Transcript
Confident tone
Oncology leadership and Seagen integration
VYNDAQEL growth and upcoming IP loss
Obesity pipeline (danuglipron)
Revenue
$13.28B
▲ 2.1% YoY Diluted EPS
$0.01
▼ 97.6% YoY Gross margin
75.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2024-05-01
Pfizer Inc (PFE) Q1 2024 Earnings Call Transcript
Positive tone
Oncology leadership and Seagen integration
RSV vaccine ABRYSVO expansion
VYNDAQEL patent and exclusivity
Revenue
$14.88B
▼ 19.5% YoY Diluted EPS
$0.55
▼ 43.3% YoY Gross margin
77.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2024-01-30
Pfizer Inc (PFE) Q4 2023 Earnings Call Transcript
Positive tone
Oncology leadership and Seagen integration
Pipeline innovation and R&D
Vaccines - pneumococcal and flu/COVID combination
Revenue
$14.57B*
▼ 42% YoY Gross margin
48.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q3
2023-10-31
Pfizer Inc (PFE) Q3 2023 Earnings Call Transcript
Revenue
$13.49B
▼ 40.4% YoY Diluted EPS
$-0.42
▼ 127.8% YoY Gross margin
31.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q2
2023-08-01
Pfizer Inc (PFE) Q2 2023 Earnings Call Transcript
Revenue
$13.01B
▼ 53.1% YoY Diluted EPS
$0.41
▼ 76.3% YoY Gross margin
75.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q1
2023-05-02
Pfizer Inc (PFE) Q1 2023 Earnings Call Transcript
Revenue
$18.49B
▼ 28% YoY Diluted EPS
$0.97
▼ 29.2% YoY Gross margin
73.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q4
2023-01-31
Pfizer Inc (PFE) Q4 2022 Earnings Call Transcript
Revenue
$25.13B*
▲ 5.4% YoY Gross margin
61.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY22 · Q3
2022-11-01
Pfizer Inc (PFE) Q3 2022 Earnings Call Transcript
Revenue
$22.64B
▼ 5.8% YoY Diluted EPS
$1.51
▲ 6.3% YoY Gross margin
73.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q2
2022-07-28
Pfizer Inc (PFE) Q2 2022 Earnings Call Transcript
Revenue
$27.74B
▲ 46.8% YoY Diluted EPS
$1.73
▲ 76.5% YoY Gross margin
68.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q1
2022-05-03
Pfizer Inc (PFE) Q1 2022 Earnings Call Transcript
Revenue
$25.66B
▲ 76.8% YoY Diluted EPS
$1.37
▲ 59.3% YoY Gross margin
61.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q4
2022-02-08
Pfizer Inc (PFE) Q4 2021 Earnings Call Transcript
Revenue
$23.84B*
▲ 108.6% YoY Gross margin
59.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY21 · Q3
2021-11-02
Pfizer Inc (PFE) Q3 2021 Earnings Call Transcript
Revenue
$24.04B
▲ 133.9% YoY Diluted EPS
$1.42
▲ 446.2% YoY Gross margin
58.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q2
2021-07-28
Pfizer Inc (PFE) Q2 2021 Earnings Call Transcript
Revenue
$18.90B
▲ 91.6% YoY Diluted EPS
$0.98
▲ 58.1% YoY Gross margin
63.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q1
2021-05-04
Pfizer Inc (PFE) Q1 2021 Earnings Call Transcript
Revenue
$14.52B
▲ 44% YoY Diluted EPS
$0.86
▲ 43.3% YoY Gross margin
71.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q4
2021-02-02
Pfizer Inc (PFE) Q4 2020 Earnings Call Transcript
Revenue
$11.43B*
▲ 520% YoY Gross margin
76.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY20 · Q3
2020-10-27
Pfizer Inc (PFE) Q3 2020 Earnings Call Transcript
Revenue
$10.28B
▼ 19% YoY Diluted EPS
$0.26
▼ 80.9% YoY Gross margin
80.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q2
2020-07-28
Pfizer Inc (PFE) Q2 2020 Earnings Call Transcript
Revenue
$9.86B
▼ 25.6% YoY Diluted EPS
$0.62
▼ 30.3% YoY Gross margin
81.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q1
2020-04-28
Pfizer Inc (PFE) Q1 2020 Earnings Call Transcript
Revenue
$10.08B
▼ 23.1% YoY Diluted EPS
$0.60
▼ 11.8% YoY Gross margin
80.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY19 · Q4
2020-01-28
Pfizer Inc (PFE) Q4 2019 Earnings Call
Revenue
$1.84B*
▲ 59.6% YoY Gross margin
76.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Showing 1–35 of 35 webcasts
Key facts
CIK
78003
CUSIP
717081103
13F (30d)
2335 filings
2175 filers
Visit website
Investor relations